| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  MJ INNOV [Automatic translation follows] Offer moments of happiness to vulnerable people (cognitive disorders/disability) thanks to the Tovertafel! MJ INNOV, a social enterprise created in 2018, offers you an innovation in care that brings moments of happiness for people living with neuro-cognitive disorders or with specific needs as well as all those around them. The Tovertafel is a fun care innovation that connects its users with each other and with their environment, while stimulating movement. These magic games were developed in the Netherlands (following 5 years of scientific research), specifically for these groups of people. The Tovertafel can be used both individually … Type: | 4 | 1 | 1 | 26 |
 | M&M Conseil [Automatic translation follows] Public affairs - Institutional relations M&M Conseil has specialized in the organization of institutional events and public affairs consulting for more than 25 years. Close to French and European institutions, we organize key meetings between public, private and institutional stakeholders. Public Affairs Consulting, Institutional Communication, Events, and Public Relations Type: | 86 | 6 | 83 | 8 |
 | Mnemo Therapeutics Mnemo Therapeutics is a biotechnology company focused on discovering and developing immune based therapies, including powerful cell therapies, that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a global team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures … Tags: FrenchTech120 Type: | 4 | 3 | 2 | 41 |
 | Molsid Time is Life. We develop life saving AMR diagnostics that are fast and reliable. Innovative BioMed company, developing a new generation of fluorogenic molecular probes, for applications such as rapid medical diagnostics, drug discovery and medical imaging, but also food quality control. Based on over 15 years of R&D at the prestigious ENS University de Lyon, Molsid’s patented SmartID technology is considered a breakthrough in high quality identification of enzyme activity in live cells. Molsid offers the broadest range of robust fluorogenic precipitation-based probes available on the market. We offer unsurpassed fast and sensitive fluorescence detection for a large panel … Type: | 7 | 2 | 5 | 14 |
 |  Moon Surgical Empowering the Surgeon Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. medical device, minimally invasive surgery, digital surgery, comanipulation, AI, Machine Learning, Surgery, Laparoscopy, and Surgical Robotics Tags: FrenchTech2030 Type: | 13 | 7 | 7 | 58 |
 | MPG - MonPetitGazon Jeux de fantasy et prédiction ⚽️ entre amis / 3m d'utilisateurs 👯♂️ / SporTech 🇫🇷 / LFP 🟢 MPG, le jeu de fantasy foot sur toute la saison 🔴 MPM, le jeu de fantasy foot sur un seul match 🔵 MPP, le jeu de prono Coupe du Monde et Euro Football, Bad jokes, ligue 1, fantasy, pronostic, and sportech Type: | 38 | 5 | 33 | 16 |
 | MSInsight Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for … Type: | 32 | 6 | 31 | 6 |
 | Music Care CARE COMPOSER: for a significant reduction in pain, anxiety and the use of medication MUSIC CARE® develops innovative tools for the prevention and management of pain, stress, anxiety and depression. The MUSIC CARE® health device is a turnkey therapeutic management offer validated by a series of controlled clinical studies. Accessible to all professionals, our assistance and support solutions open up innovative perspectives for the world of health and well-being. MUSIC CARE® is now present in numerous hospitals, private clinics, senior citizens' homes and spa centers. Our strengths * Effectively manage pain*, anxiety, stress and depression * Significantly reduce drug consumption … Type: | 3 | 3 | 0 | 15 |
 | myCharlotte [Automatic translation follows] Day after day, myCharlotte helps you reduce the side effects associated with breast cancer treatments myCharlotte offers activities with a documented impact on reducing the side effects of breast cancer treatments. Every day a personalized program is offered to you based on your profile and your side effects and you do the activities using video and audio recordings. digital health, supportive care, life habits, Quality of Life, cancer, and e-health Type: | 29 | 6 | 29 | 11 |
 | myDiabby Healthcare [Automatic translation follows] The telemedicine platform for diabetes monitoring. myDiabby has been the leading diabetes remote medical monitoring platform in France for 9 years. Specializing in the monitoring of type 1, type 2 and gestational diabetes, the first patients have benefited from reimbursement from the platform by health insurance since July 2023. Used by the majority of university hospitals, hospitals, clinics and city doctors connected in a vast French-speaking network, myDiabby is the most widespread telemedicine platform dedicated to the management of diabetes in France. Several thousand patients are registered each month and benefit from telemedical monitoring throughout the country. … Type: | 7 | 1 | 6 | 22 |
 |  MY HOSPITEL [Automatic translation follows] Hospital care, nights in a hotel. My Hospitalel publishes the first management platform for the hotel-patient system. Thanks to its solution, it facilitates the sending of patients eligible for HTNM* to the hotel, without administrative overhead for hospital staff. Our digital solution adapts to all types of establishments at no additional cost. Our digital tool allows beds to be quickly reallocated by eliminating unnecessary overnight stays and thus limits the rescheduling of operations. My Hospitel increases the reception capacity of hospital establishments while ensuring patient comfort during their care journey. The patient becomes an actor in his … Type: | 13 | 6 | 1 | 41 |
 |  Myotact Innovation for patient autonomy Myotact is a medical device that detects muscle activity by EMG and translates it into virtual movement with vibrotactile feedback. Type: | 23 | 5 | 22 | 1 |
 | MYRIAGONE CONSEIL [Automatic translation follows] Consulting company specializing in growth through innovation. Our 3 pillars: strategy, science and creativity. Myriagone Conseil supports companies in their growth through innovation. At the crossroads of science, strategy and creativity, we enable SMEs, VSEs, start-ups, ETIs or large groups to generate added value over time. Our expertise: - Business strategy - Innovation Management System - Financing Innovation innovation strategy consulting, innovation taxation, creativity, structuring, Research Tax Credit, innovation management, start-ups, and management consulting Type: | 34 | 5 | 31 | 17 |
 | My-Serious-Game My business is Serious, learning it is just a Game. France’s No.1 in tailor-made Digital Learning Solutions turns your training courses into pedagogical, collaborative & immersive experiences. Digital learning, Video Based Training, Adaptive Learning, Corporate Training, Serious Game, E-learning, Digital Training, Formation, Formation professionnelle, Gamification, Virtual Reality, Blended learning, Formation digitale, and Formation sur-mesure Type: | 22 | 4 | 17 | 42 |
 | mYXpression Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence … Type: | 18 | 4 | 17 | 8 |
 | NAAREA [Automatic translation follows] Energy is the question of the future for humanity and the planet! The goal of NAAREA is to make the continued development of human activities compatible with the protection of the heritage and heritage of humanity that constitutes the climate of our planet. This purpose depends directly on energy. Achieving the 17 Sustainable Development Goals of the United Nations 2030 Agenda is an absolute necessity for humanity (eradicate poverty, protect the planet, guarantee prosperity). Tags: FrenchTech2030 Type: | 26 | 6 | 18 | 138 |
 | Nanobiose Smart tools for cell biology Nanobiose’s mission is to provide pharma, biotech and cosmetic companies with better tools to improve their in vitro analysis of efficacy / safety of drug candidates. Nanobiose develops SecretCells®, an innovative lab-on-a-chip system to evaluate secreted biomarkers from 2D or 3D perfused cells. SecretCells® combines a microfluidic biochip (where the perfused 3D cell cultures stand) and a removable biosensor for a multiplexed on-line biomarkers analysis. While better mimicking in vivo like conditions, SecretCells® allows more accurate and more predictive results for the evaluation of drug candidates at early stages. SecretCells® is a very flexible solution … Type: | 18 | 0 | 18 | 4 |
 | Natéosanté French designer and manufacturer of solutions for controlling and purifying indoor air in the workplace. NatéoSanté has been the French specialist in indoor air quality since 2009. As a player in the healthcare innovation ecosystem, we work every day to prevent occupational, nosocomial and respiratory diseases linked to poor air quality, a major public health issue. NatéoSanté has real expertise in the air industry and a perfect command of the issues specific to many professional environments. We offer a complete range of air measurement and purification solutions for professionals, and support establishments from A to Z in their efforts to … Type: | 18 | 4 | 16 | 19 |
 | Neoplants The first generation of plants bioengineered to fight air pollution. www.neoplants.com The first plant-microbiome systems bioengineered to purify indoor air. | 15 | 10 | 8 | 36 |
 | NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology Type: | 28 | 9 | 23 | 39 |
 | NewCap [Automatic translation follows] Investor Relations & Strategic Communications Created in 1999, NewCap is an independent consulting company specializing in financial and institutional communications. Our team of finance and communications professionals is focused on implementing programs adapted to the strategic objectives of managers and the specific expectations of the financial community. Our strategic and operational approach is backed by a proven methodology and permanent feedback for better communication of the vision of managers. Our offer meets all of the financial and institutional communication objectives of a listed company and is based on three professions: consulting, relationship marketing and optimal management of … | 27 | 3 | 26 | 30 |
 | NEWCARD [Automatic translation follows] The Remote Monitoring Solution for Chronic Pathologies / We are recruiting 🚀 Founded in 2016 by a cardiologist, Newcard is a company specializing in the remote monitoring of chronic diseases. Our objective ? Offer a quality service for patients and healthcare professionals, and support doctors in integrating this activity into their daily practices. The company, which currently has around thirty employees, provides two services 100% covered by Health Insurance: - “1 Minute for my Heart”: intended for cardiologists to monitor their heart failure patients. - “1 Minute for my Kidneys”: offered to nephrologists for the follow-up of … Type: | 15 | 4 | 11 | 46 |
 | nexialist Tomorrow's health is being built today Nexialist is a consulting firm specializing in regulatory intelligence and compliance of healthcare products In the healthcare field, regulations are constantly being tightened and their application has become the number one challenge for company managers! In this context, being accompanied by nexialist is to ensure, thanks to a multidisciplinary team of experts and proven working methods : . to deal with regulatory affairs in complete serenity, by anticipating regulatory changes, . to increase the competence of internal teams through adapted training programs, . accelerate the access of products to the market and maintain them … Type: | 12 | 6 | 8 | 35 |
 | Nextmed Strasbourg Strasbourg Medical Technologies An international benchmark for improving health care and enhancing medical skills santé, innovation, medtech, business, patient, care, and prévention Type: | 31 | 8 | 27 | N/A |
 | NG BIOTECH Rapid, mobile, connected diagnostics At NG Biotech, we develop, manufacture and commercialise rapid, mobile and connected diagnostics to modernize diagnosis practice worldwide. NG Biotech is a French company specialized in Research & Development, Manufacturing and Marketing of a new generation of "multiplex", "quantitative" and "connected" rapid diagnostics for biomarker analysis and/or therapy monitoring at the Point of Care. NG Biotech’s patented platform is rapid, mobile and connected. It allows to simultaneously analyse up to 9 biomarkers from a biological direct sample such as a single finger-prick drop of blood. The results can be sent via smartphone within five minutes. NG … Type: | 9 | 3 | 5 | 56 |
 | NORAKER [Automatic translation follows] Bioglass Solutions for Bone Regeneration NORAKER, a French player in regenerative medicine,'s mission is to promote the reconstruction of the bones of patients who have undergone orthopedic or dental surgery. A spin-off from INSA Lyon in 2005, NORAKER innovates with its mastery of a biomaterial with exceptional properties: bioactive glass. NORAKER has been distributing its implants since 2015, with an international presence in more than 40 countries. The company invests in close and regular collaboration with surgeons and healthcare professionals, to always better meet the requirements of the medical environment. NORAKER products find their application in orthopedic, … Type: | 13 | 5 | 11 | 37 |
 | Normand'e-Santé (NeS) [Automatic translation follows] Our connected health! Normand’e-Santé is legally a private, non-profit Health Cooperation Group (GCS). Identified as GRADeS, for Regional Support Group for the Development of e-Health, NeS is the preferential operator of the ARS of Normandy and deploys the national and regional strategy in terms of e-health. He is the project manager of the Regional Health Digital Space in Normandy. The objective of the group is to improve the overall and coordinated care of patients in Normandy. It is based around the principles of continuity and quality of care, respect for patients' rights, traceability of interventions and strengthening … Type: | 15 | 2 | 11 | 51 |
 | Normandie Participations [Automatic translation follows] By your side, in all your challenges! What could be more natural than a regional investment fund to contribute to the dynamism of its territory? Normandie Participations is the investment fund of the Normandy Region. With an initial capital of €100 million, it deploys a total of nearly €200 million, particularly through its various tools (debt funds, coastal funds, rebound funds). Normandie Participations addresses all of the financing needs of companies, from innovation capital to development capital and transmission capital. With a team of 10 people combining technical skills and operational experience and comprising governance of business … Type: | 19 | 2 | 19 | 15 |
 | Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: | 12 | 10 | 2 | 7 |
 | NovAliX NovAliX is a preclinical drug discovery-focused CRO NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand … Type: | 27 | 4 | 25 | 379 |
 | NOVAPTECH The Aptamer Expert Company Novaptech develops aptamer-based tools in the frame of technology transfer and innovation projects. Novaptech’s expertise is focused on the identification and the characterization of aptamers for biotechnological development of analytical and diagnostic aptamer projects. Novaptech develops collaborative projects or service agreements with academic laboratories and R&D department of companies. Novaptech works in close association with Dr. Toulmé ’s team, an academic laboratory (Inserm U1212, Bordeaux) which has more than 26 years of experience in aptamer selection. Research and Development and Therapeutics and Diagnostics Type: | 1 | 1 | 0 | 11 |
 | Novaxia [Automatic translation follows] Our mission ? Give everyone the means to sustainably transform the city! Novaxia is a leader in real estate development capital. Its job: to enhance investors’ savings by bringing real estate to life. With dual expertise in finance and real estate, Novaxia has developed a unique method which reconciles the interests of the different stakeholders involved in a project: investors, owners, elected officials and communities, landlords. Its objective: to benefit all stakeholders from the creation of value resulting from the recycling of obsolete urban assets (buildings, warehouses, wastelands) and the creation of living spaces. Each project is … Type: | 67 | 24 | 46 | 101 |
 | Novéka ! [Automatic translation follows] Taking care of innovation Entirely dedicated to connecting and collaborating individuals, Novéka contributes to promoting the skills and know-how of the local ecosystem in the service of innovation, transformation and development of companies in the health sector and, in particularly medical devices and e-health in the AURA region. Type: | 28 | 13 | 23 | 5 |
 | NOVIGA [Automatic translation follows] A heartbeat away from your sleep Our objective ? May the underdiagnosis of sleep apnea become nothing more than a distant nightmare because today, 80% of patients are undiagnosed! 💤 NOVIGA offers healthcare professionals a medical software device for evaluating sleep apnea syndrome using a long electrocardiogram. Our solution supports doctors in screening their patients at risk, while integrating into their daily practice. From Esperanto “innovation”, NOVIGA carries in its genes this desire to provide the health sector with digital solutions integrating artificial intelligence and responding to the challenges of today’s world. For more information, consult our … Type: | 18 | 4 | 14 | 4 |
 | Nūmi (ex-MUMilk) At Nūmi, we're on a mission to redefine infant health through groundbreaking research and innovations. We’re working to recreate the magic of in vivo breast milk in vitro, offering parents a natural choice when breastfeeding isn’t an option. Type: | 6 | 6 | 0 | 11 |
 | Nurea Enhance medical images to prevent cardiovascular accidents! Patients are more important than everything. On a daily basis, we focus on and improve the way surgeons care patients. We put all of our expertise to enhanced patient follow-up and simplify surgeons life. Medical images were the last revolution in patient care. We believe they are still under exploited. We believe that new powerfull technologies can help and we want to bring it to surgeons. Easily and intuitivly. These technologies are relevant only if it is simple and give the right information at the right moment. Every day, we work hard to … Type: | 9 | 4 | 6 | 13 |
 | Observia Improve patients' lives Since 2011, we have been a passionate pioneering health tech company committed to driving the healthcare (r)evolution and improving patients’ lives. We work with healthcare stakeholders that aim to create value at every step of the patient journey: industrial companies, healthcare facilities, healthcare professionals, and patient organizations. As a European reference, we help companies to develop personalized, intelligent patient engagement and support solutions, and to define and implement patient strategies. We have created a new generation of evidence-based tools to support efficient patient behavioral change and improve the user experience. d.tellsTM, our smart engine for personalizing patient … Type: | 13 | 2 | 13 | 52 |
 | Octapharma Our passion drives us to provide new health solutions advancing human life Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs nearly 12,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 195 plasma donation centres across Europe and the US. Octapharma has 40 years of … Type: | 3 | 3 | 0 | 2,431 |
 | Octopize Proven Privacy: Unlocked Data. ✅ We unleash data value with anonymous synthetic data #avatar. We unleash data value with anonymous synthetic data : #avatar. Avatar guarantees individual privacy without compromising data quality. 🚀 Type: | 79 | 8 | 69 | 18 |
 | Okantis [Automatic translation follows] Okantis supports you in the transformation of your information system. Okantis is a public interest group specializing in digital health for over 35 years; based in Limoges and Poitiers and mobilizing nearly 200 expert collaborators throughout France, including overseas territories and territories, Okantis pools with its members a galaxy of high-performance services allowing them to deploy, maintain, train and interconnect software and management systems. information from healthcare establishments. Approved HDS health data host and third-party digital archiver. In a spirit of public service, our cooperation group acts so that the information system constitutes an efficient and innovative … Type: | 20 | 6 | 15 | 130 |
 | O-Kidia Le transdiagnostic au cœur d’une clinique numérique grâce à une IA biomédicale et multimodale - Neurodéveloppement The startup O-Kidia develops software applications for health professionals to support diagnosis and right care in children and adolescents with neurodevelopmental and related mental disorders. We combine cutting-edge machine learning and biometry to identify digital biomarkers that will facilitate diagnosis and therapeutic decision making of neurodevelopmental and related mental disorders for health professionals. Our digital tools measure contactless, by a simple 30-minutes video, mental-related parameters: attention, social, anxiety, emotional, behavioral, motricity, visual speed, sleep variables to support diagnosis and therapeutic decision making for health … Type: | 25 | 10 | 18 | 9 |
 | Oncodesign Services A leading CRO in drug discovery and preclinical services Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing, Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.). Oncodesign Services offers a full spectrum of services in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology (including humanized models). This … Type: | 12 | 8 | 5 | 20 |
 | OPTACARE [Automatic translation follows] People at the heart of our innovations The organizational tensions that affect the functioning of healthcare establishments require innovative and efficient responses. The flow forecasting and constrained planning solutions developed by OPTACARE are decision-making tools that concretely respond to these challenges. OPTACARE offers a range of 360° solutions that respond to all the organizational challenges that healthcare establishments face. We equip caregivers with solutions that are easy to use and which free up more care time for them to spend with their patients. We develop : - Forecasting solutions: to anticipate scheduled and unscheduled flows and size … Type: | 7 | 3 | 7 | 19 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 17 | 8 | 12 | 10 |
 | Orano Med Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information … Type: | 6 | 2 | 6 | 124 |
 | Orchard Therapeutics Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy. At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment. In 2018, the company acquired GSK’s rare disease … Type: | 2 | 2 | 0 | 204 |
 | Orphalan At Orphalan we strive to develop rare disease treatments to improve patients lives. Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. | 3 | 2 | 2 | 106 |
 | Osivax Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company … Tags: FrenchTech2030 Type: | 22 | 11 | 13 | 53 |
 | OSO-AI [Automatic translation follows] Detection of all needs. Revolutionizes care practices. 150 classes of sounds and noises analyzed by AI OSO-AI, a deeptech start-up pioneering Ambient Intelligence, has developed a unique technology in the world: “Caregivers’ Augmented Ear”TM. This innovative solution, making the most of artificial intelligence and the recognition of noises and sounds, allows secure and remote monitoring of vulnerable people and users of medico-social establishments while improving the quality of life at work. healthcare workers. Objective: Detect any abnormal noise (fall, cry, call, respiratory distress, vomiting, etc.) from residents to alert caregivers. - 150 categories of sounds and noises … Type: | 32 | 12 | 21 | 33 |
 | Ospi (Groupe PSIH et Collective Thinking) [Automatic translation follows] Data and AI for health Ospi, born from the merger between the PSIH Group and Collective Thinking, is a key player in medical coding, clinical research and quality of care. Software, Health, Business Intelligence, BI, Hospital, Data Hosting, Data Science, EDS, and Cybersecurity Type: | 24 | 1 | 21 | 87 |
 | Owkin We use AI to find the right treatment for every patient. Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from … Type: | 32 | 12 | 22 | 438 |
 | Oxford Properties Group We are a global real estate investor, developer and manager. Established in 1960, Oxford and our platform companies manage nearly $87 billion of assets with a portfolio of 158 million square feet of commercial space. Our global portfolio includes workplace, life sciences, industrial, shopping, living, hotels & alternatives and credit assets on four continents. A thematic investor with a committed source of capital, we invest in properties, portfolios, development sites, debt, securities and platform companies across the risk-reward spectrum. Oxford is backed by OMERS, which has a diversified, global portfolio of public market, infrastructure, private equity, venture capital and real … Type: | 14 | 2 | 6 | 1,666 |
 | Oxyledger Reinvent the traceability of implantable medical devices to democratize and simplify clinical follow-up Our mission: Build secured and protected global Medical Device Health Registry by collecting data at the point of use in the Operating Room for practicing evidence-based medicine and tracing implantable devices to protect patient safety and meet regulatory compliance. Traçabilité, Santé, Prothèses, Dispositifs médicaux, Implants, DMI, IUD, DM, Wiki, Bloc opératoire, GS1, UDI, and Wiki Type: | 9 | 3 | 9 | 10 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 15 | 4 | 8 | 10 |
 | PariSanté Campus [Automatic translation follows] ParisSanté Campus, here grows digital health! PariSanté Campus aims to create a coherent and synergistic set of public and private operators, with the ambition of structuring a digital health research and innovation sector with global reach. This group will aim to be established on the site of the former Val-de-Grâce army training hospital, and to create a network of Ile-de-France, national and international partnerships. The whole will be financed by unprecedented investments from the recovery plan, and will be intended to be a major vector for creating medical-scientific, but also economic, value. Based on a complete chain … Type: | 77 | 24 | 47 | 20 |
 | Paris Saclay Cancer Cluster (PSCC) Bringing together the actors of oncology innovation to develop solutions in France for the patients. As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient. 🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories. 🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation … Type: | 23 | 8 | 19 | 15 |
 | PepKon PepKon is a french biotechnology company founded in 2022. The company develops first-in-class peptides for the treatment of incurable or poor prognosis cancers. These drug-candidates come from over a decade of academic research, resulting in seven scientific publications and two patent families Type: | 6 | 4 | 4 | 7 |
 | Pharmaceutiques [Automatic translation follows] Reference information for the pharmaceutical sector Since 1992, economic, political and regulatory news from players in the pharmaceutical and health industries: • Organization of the health system • Legislation and regulations • Laboratory strategies • Business news and market trends • Monitoring of public and private partners • Report on major events in the sector • Biotech/medtech news • Portraits of personalities • Appointments • Cross-cutting thematic files Type: | 55 | 11 | 50 | 69 |
 | Pherecydes Pharma At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of … Type: | 13 | 10 | 4 | 13 |
 | PhinC Development 15 ans de modélisation en pharmacologie appliquée au développement des candidats-médicaments PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the regulatory authorities … Type: | 6 | 2 | 5 | 16 |
 | Phost'in Therapeutics Unmask Cancer, Elicit Immune Response Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors. Glyco Immuno Oncology Type: | 11 | 5 | 7 | 15 |
 | Pixacare Turning smartphones into powerful medical devices 📲 Medical photo management, Wound management, Artificial intelligence "Frédéric Bodin, Professor of Plastic Surgery, was taking over 200 photos a week and had no tools to sort and store them safely. In 2018, he went to a health innovation competition with the idea of creating an app to manage his medical photos. It was there that he met entrepreneur Matis Ringdal and engineer Vincent Marceddu. The prototype app they developed won several awards. "It all came together in 2019 when they founded the company and signed their first hospital contracts. Pixacare won the i-Lab … Type: | 21 | 7 | 14 | 22 |
 | Pixee Medical A new vision for computer assisted orthopedic surgery Pixee Medical is developing a new generation of computer assisted surgery tools using augmented reality and mixed reality. A simple pair of smart glasses allows the navigation of prostheses without percutaneous bone reference, nor associated consumable. Our dedicated instrumentation automatically transfers essential anatomical landmarks to the software. The surgical parameters are then displayed on a virtual screen combining real and virtual images. To do this, our company has developed proprietary software tools to use the simple camera from glasses to accurately locate bone structures and instruments. Our customizable workflows provide the surgeon … Type: | 20 | 14 | 10 | 47 |
 | Planktovie Innovation for Aquatic Animal Research Planktovie’s vision is to develop planktonic nutritional solutions meeting the highest standards for the maintenance of your aquatic animal models, and helping to fulfill the 3Rs (Reduce, Refine, Replace the use of animals for scientific purposes) concept (http://www.nc3rs.org.uk/). Aquatic animal models are gaining in importance as alternatives to more conventional models such as rodents. The use of zebrafish is rapidly expanding in both basic and applied research in areas such as clinical research, pharmacology, and drug discovery. The husbandry requirements of zebrafish, and especially their nutritional needs, have a massive impact on both the number … Type: | 7 | 2 | 5 | 4 |
 | Plantibodies A sustainable delivery platform for oral biologics. Plantibodies is a biotech developing a sustainable platform to produce and deliver oral biologics with increased efficacy and less adverse side effects for the patients. Thanks to molecular farming and synthetic biology, our technology enables to produce humanized monoclonal antibodies within edible plant leaves instead of using animal cells, while drastically reducing carbon footprint, slashing production costs by over 90%, and offering medications with remarkable room temperature stability. By effortless storage and a potential worldwide distribution to treat diseases at home such as cancers, inflammations, metabolic diseases and infections, Plantibodies avoids burdensome intravenous … Type: | 5 | 2 | 4 | 7 |
 | Plasseraud IP We take care of your IP Founded in 1906, Plasseraud IP is one of the leading European firms in the IP sector, and among the largest in France. Our team of over 175 Attorneys (Patents, Trademarks & Designs) ensures that our clients’ needs are taken care of by specialists in all technical and legal areas. Our Attorneys are all highly technically and/or legally qualified and include: French Patent Attorneys European Patent Attorneys French Trademark & Designs Attorneys European Trademark & Designs Attorneys We are a full service IP firm, and our activities include: Filing and prosecution of patents, trademarks and … | 37 | 5 | 35 | 361 |
 | Poietis Make tissues real Poietis (gr. Ποίησις: to make). "The one who makes things real." Poietis is a health-tech company specialized in the development of solutions for manufacturing human tissues by 4D Bioprinting. Poietis commercializes its Next Generation Bioprinting (NGB) systems for Cell Therapy & Research Centers and also develops advanced therapies with leading clinicians. 4D Bioprinting, Tissue engineering, Laser, bioprinting, skin, and cell therapy Type: | 12 | 8 | 5 | 22 |
 | Pôle BFCare [Automatic translation follows] Bringing together healthcare companies in Burgundy-Franche-Comté to stimulate innovation and attract young talents The BFCare cluster is an association made up of around fifty companies in the health products and services sector, based in Burgundy - Franche Comté, and partners interested in health activities (institutions, private rights organizations, etc.). .). The main objective of this association is: - to facilitate the emergence of cooperation and synergies between members and external actors, - encourage exchanges of good professional practices to develop the competitiveness of businesses - and support regional attractiveness in terms of investment and talent. health, medical … Type: | 17 | 4 | 13 | 3 |
 | POLEPHARMA [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Polepharma structures the French (bio)pharmaceutical industrial sector and has been supporting its transformation for 20 years. Polepharma has become the first pharmaceutical industrial cooperation in Europe, between areas of excellence and players in the sector: 400+ members, 60% of production & 70k jobs in France. Established in 5 territories (Centre-Val de Loire, Ile-de-France, Normandy, Occitanie, Nouvelle-Aquitaine), Polepharma supports its members throughout France. These are laboratories, suppliers, schools, collectives, experts, talents who want to make France the best place in the world to develop & produce medicines, that is to say cutting-edge, virtuous, … Type: | 48 | 27 | 27 | 28 |
 | POLYGON Therapeutics Innovation. Applied. Bringing life to life. POLYGON Therapeutics aims to address unmet therapeutic needs through innovative breakthrough approaches. Within its first therapeutic development program EMOTION, POLYGON aspires to transform cardiovascular diseases care. Type: | 12 | 5 | 10 | 9 |
 | Polymny Studio [Automatic translation follows] Polymny is the web studio for trainers who create, modify and manage educational videos! Polymny is the web studio for trainers who create, modify and manage educational videos! Type: | 10 | 3 | 3 | 3 |
 | PONANT Technologies [Automatic translation follows] Design office expert in the development of solutions in industrial, embedded computing and automated testing. Created in November 2015 in Valence (26), PONANT Technologies is a design office expert in the development of solutions in industrial computing, embedded computing and specialized in testing. Drawing on our experience in the development of embedded software, we have designed, developed and patented eTASQ Motion, a robot dedicated to the automated and non-intrusive testing of electronic products through their HMI (human-machine interface). This unique solution, made in France, already deployed for more than three years, is the alternative to manual testing. … Type: | 16 | 5 | 15 | 38 |
 | Portzamparc Groupe BNP Paribas [Automatic translation follows] Portzamparc, a French leader in stock market support for private clients, management companies and SMEs. A historic player in the financial markets, Portzamparc has more than 150 years of experience in the stock market business. Portzamparc develops a triple advisory and intermediary activity with individuals, but also institutional investors and companies, for which it carries out financial operations (IPOs, capital increases, etc.) and manages liquidity contracts. The subsidiary Portzamparc Gestion is specially dedicated to mandate management and markets a wide range of funds responding to different investment strategies. A strong conviction: maintain the fundamental role of the … Type: | 41 | 5 | 29 | 174 |
 | Posos Posos is the world's most advanced artificial intelligence platform dedicated to medical prescriptions. Founded in 2018, Posos is a MedTech company that has built the world's most advanced artificial intelligence platform dedicated to medical prescriptions. It seamlessly integrates into a hospital’s electronic medical records, enabling healthcare prescribers to use AI to prescribe in real-time, based on the best recommendations. Co-created by Posos' pharmacists and engineers, the platform has received approval from health authorities in France. Its powerful AI assistant speeds up and optimizes the prescribing process, which is currently very time-consuming and approximate within EHR. Posos can drive massive patient … Type: | 28 | 14 | 18 | 67 |
 | POXEL Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate … Type: | 2 | 2 | 0 | 27 |
 | Pramex International [Automatic translation follows] To establish yourself abroad by creating a subsidiary or acquisition Pramex International supports French start-ups, SMEs and mid-sized companies in their projects to establish themselves abroad, through the creation of a subsidiary or acquisition. -We assist our clients during the creation of their international subsidiary(ies), then in their daily administrative management(s): accounting, taxation, human resources, life social, reporting, etc. - We also advise French SMEs and mid-sized companies in their international acquisition projects on operations of €5 to €150 million (transaction value). With an integrated network of 17 locations spread across 13 countries (Europe, United States, Brazil, … | 15 | 5 | 11 | 164 |
 | Praxy.ai The AI suite for healthcare professionnals Praxy.ai, founded by doctors and AI engineers, has developed an AI suite for healthcare professionals, our products free up their time, while improving the completeness and precision of therapeutic patient monitoring. Our first product on the market is a multi-channel solution (physical consultation, telephone, videoconferencing, mobility) which automatically generates consultation reports and updates patients' medical records. IA, Santé, Langage médical, Prestataires de santé à domicile, SaaS, HDS, Robotic process automation, LLM, Deeptech, Deeplearning, NLP, Mon Espace Santé, and logiciel médical Type: | 5 | 3 | 3 | 11 |
 | Predict4Health AI-powered Precision Medicine for Organ Failure Our mission is to improve patients’ live and healthcare systems by postponing organ failure with the power of AI. 💪 Our products : 📊 A Decision making tool based on iBox : Predigraft helps physicians monitor transplanted patients by providing allograft survival prognosis. 📱 A Smart telemonitoring of chronic patients : Apilife is a fully connected platform acting as a medical hub for patients and their medical teams. 🧬 A Digital Biomarker for clinical trials : Our technology can be used to design clinical trials and to assess kidney allograft survival. Medicine, Machine Learning, … Type: | 39 | 5 | 30 | 28 |
 | Préfecture de la région Bourgogne-Franche-Comté, préfecture de la Côte d’Or [Automatic translation follows] Account of the prefecture of the Burgundy-Franche-Comté region, prefecture of Côte-d'Or. Find on the page of the prefecture of Côte-d'Or and the Burgundy-Franche-Comté region the job offers to be filled within our services, the action of the State in the territory or even the administrative news for businesses. Type: | 40 | 12 | 30 | 109 |
 | PREVIA MEDICAL Artificial Intelligence detecting patients complication risks, compatible with all major EHR systems with FHIR PREVIA is an artificial intelligence capable of forecasting pathologies. Compatible with all major EHR systems using FHIR technology, it analyzes the data of thousands of patients in real time and accurately identifies the complications risks. The first score SEPSI-SCORE, MD certified in 2021, alerts up to 48 hours before the first symptoms of sepsis. Health care professionals can trigger treatment protocols earlier, reducing lengths of stay and saving lives. AI, FHIR, HEALTHCARE, MACHINE LEARNING, ESANTE, Medecine predictive, SEPSIS, and INNOVATION Type: | 9 | 1 | 8 | 6 |
 | ProductLife Group ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. Since almost 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 130 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. Data Management, … Type: | 4 | 2 | 2 | 1,106 |
 | PROMÉTHÉE Earth Intelligence [Automatic translation follows] PRESERVING HERITAGE FOR SUSTAINABLE FUTURE Prophéée Earth Intelligence is the first French Newspace operator of a constellation of earth observation nanosatellites whose objective is to democratize the use of satellite imagery for a safer and more sustainable world. PROMÉTHÉE Earth Intelligence thus responds to the challenges of crisis management and sustainable development by providing strategic intelligence and environmental intelligence services. The field of application that PROMÉTHÉE Earth Intelligence offers is practically unlimited, from maritime surveillance to critical infrastructure; including the protection of ecosystems, water resources, fauna and flora; the fight against deforestation, illegal fishing and even prevention … Type: | 46 | 11 | 45 | 42 |
 | PTC Therapeutics, Inc. We're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones. PTC is a science-driven, patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease. Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives Type: | 3 | 1 | 2 | 1,230 |
 | P'tit Bout de Lumière [Automatic translation follows] Make care child's play! P'tit bout de Lumière develops interactive stories in virtual reality specifically for children during dental care. We offer healthcare professionals a distraction solution for children during invasive care. Thanks to virtual reality glasses, the child is transported into an imaginary world where successive phases of conversational hypnosis, breathing exercises and interactive games take place. Support in providing care Type: | 9 | 6 | 4 | 7 |
 | PulseLife (ex 360 medics) [Automatic translation follows] PulseLife, for informed medical decisions. PulseLife instantly answers caregivers' medical questions and simplifies updating their knowledge. Medical search engine, clinical app ecosystem and scientific monitoring: instantly access information that allows you to make informed clinical decisions. More than 700,000 caregivers including 350,000 doctors using it worldwide. ____________ - Your new way to search for medical information Thanks to our medical search engine, finding the answer to your medical questions has never been so quick, simple and reliable! -> Do you have questions about a pathology and its associated therapeutic strategy? Access the latest recommendations and decision trees … Type: | 52 | 3 | 49 | 50 |
 | Qarnot More IT, less energy, less carbon! Qarnot is a french company, incorporated in 2010, providing its clients with a unique solution to drastically reduce their carbon footprint linked to their digital activities. Instead of concentrating servers in datacenters, our strategy relies on a computing power infrastructure distributed in buildings (offices, housings, public facilities, factories, warehouses) where huge amounts of heat generated by IT servers can be locally and directly valued. This alternative way brings a global and important cost, risk and carbon footprint reduction of our clients digital infrastructure compared to the traditional data center approach, especially concerning high performance … Tags: FrenchTech2030 Type: | 55 | 20 | 42 | 82 |
 | Quantiq Healthcare The AI video-based health monitoring solution. We transform any webcam or smartphone into a Medical Device. We measure heart rate, frequency rate, SpO2 and more just by analysing your face with a camera ! Type: | 23 | 1 | 23 | 16 |
 | Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex. Drug Discover, Computational Chemistry, Molecular Dynamics Simulation, and Quantum Physics Tags: FrenchTech2030 Type: | 46 | 17 | 36 | 59 |
 | Quest for change [Automatic translation follows] Grand Est incubator network Since 2018, 6 incubators of excellence in the Grand Est region, spread across 6 territories (Charleville-Mézières, Epinal, Metz, Mulhouse, Reims and Strasbourg), have deployed a common support methodology. This method, sequenced and tested by more than 260 start-ups to date, aims to lead/bring project leaders to meet their market and achieve their financial independence. Our team, made up of 45 experts with strong entrepreneurial DNA, aims to develop innovation in our territory via pragmatic, caring and impartial support. Type: | 77 | 23 | 72 | 28 |
 | Quest for health [Automatic translation follows] Healthcare accelerator in the heart of Europe. For biotech, medtech and digital health startups. Quest for health is the Grand Est incubator dedicated to health start-ups at European level. Born from the initiative of the Quest for change network of incubators (based in Reims, Strasbourg, Metz, Charleville-Mézières, Epinal and Mulhouse), the incubator supports more than sixty biotech, medtech and e-health start-ups. Quest for health is positioned as the leading player at the national level in this field. Among the start-ups supported, 21 are winners of the national i-Lab competition (including four grand prizes), five of the i-Nov … Type: | 40 | 11 | 38 | 6 |
 | Qynapse The future of neuroimaging is here. Qynapse offers groundbreaking peace of mind by providing results you can trust. The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust. Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and … Type: | 8 | 3 | 5 | 22 |
 | Rarecells Detect and defeat cancer from its start through a simple blood draw. Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique … Type: | 1 | 1 | 0 | 21 |
 | RDS Advancing Patient PathwaysTM RDS is a French Start-Up / MedTech based in Strasbourg, France. We leverage best-in-class biosensor technologies, combined with the latest developments in digital and predictive medicine, and bring to life the next generation of Patient Monitoring Solutions. Our main product, MultiSense®, offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. RDS relies … Type: | 33 | 6 | 21 | 34 |
 | ReACT Therapeutics [Automatic translation follows] Breaking resistance barriers in oncology. ReACT Therapeutics is a French biotech company working to restore the effectiveness of cancer treatments and improve the quality of care provided to patients. Created in January 2023 in Grenoble, ReACT Therapeutics aims to develop a new class of molecules capable of blocking the phenomena of multi-resistance responsible for therapeutic failures. ➡️ Our mission: Work for and with patients to restore the effectiveness of their cancer treatments and improve the quality of their care. ➡️ Our goal: Develop a new class of molecules capable of blocking multi-resistance phenomena in oncology. The result … Type: | 13 | 6 | 9 | 2 |
 | RebrAIn ReBrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated. Type: | 11 | 7 | 6 | 12 |
 | Recare We are reshaping discharge management Recare is a web-based, digital platform that facilitates an effective patient transfer from hospital to care providers. Our smart search tool sends targeted requests to potential providers and enables real-time, secure communication between both sides. The process is faster and more transparent for all - hospital staff, care providers, and patients. Type: | 5 | 1 | 4 | 111 |
 | REEV (techstars '23) Building the future of walking assistance 🦿 At REEV our mission is to help 50 million people affected by walking disorders like strokes to overcome their disability by becoming more autonomous and independent in their daily movements. To achieve this mission, we are making a smart and patient-centric robotic orthosis providing a light assistance to walk, stand, sit and climb stairs more easily everyday. We do this because we believe everyone deserves to enjoy their mobility to the fullest everyday, regardless of their level of disability or age. Let's join the Motion Crew 🦿! Type: | 11 | 9 | 5 | 23 |
 | REGEnLIFE Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, … Type: | 13 | 2 | 11 | 12 |
 | Reims Légend'R [Automatic translation follows] Reims Légend’R, the territory to write your legend. #Business #Events #Jobs #Life #Study #Visit #TousLegendR Reims Légend’R is the regional brand of Greater Reims serving tourist, economic, student and even residential attractiveness. It is a collective project, involving all the driving forces with a common objective of promotion, influence and development of the territory united under the same banner, Reims Légend’R. Because Reims Légend’R is a story to tell, a banner to share, a legend to write! #AllLegendR territorial marketing and communication Type: | 99 | 8 | 98 | 13 |
 | Relyens en France [Automatic translation follows] European mutual insurance and risk management group specializing in healthcare and regional players. Anticipate today to protect tomorrow. At Relyens, we are much more than an Insurer, we are Risk Manager. Managing, preventing and insuring risks is our commitment to more effectively protect health care providers and territories in Europe. Alongside them, we act and innovate in favor of an ever safer service of general interest, for everyone. Relyens has 1,100 employees committed to serving healthcare stakeholders and regions, in France, Spain, Italy, Germany and Belgium. To secure their activity and guarantee the quality of services delivered … Type: | 28 | 7 | 19 | 1,084 |
Startup